Contracts & Pricing April 21, 2021 Updates to State Price Transparency Reporting, Medicaid Laws 3 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Contracts & Pricing April 14, 2021 The Current State of Pharmaceutical Price Transparency Reporting 2 Minute Read What you need to know about navigating a patchwork of state policies, achieving operational readiness, and avoiding compliance risk.
Contracts & Pricing March 11, 2021 Changes to Medicare Part D, Drug Rebate Program, OIG Final Rule 5 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Contracts & Pricing February 16, 2021 New ASP Reporting Requirements, 340B Drug Pricing Program and Final Rule,... 4 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Gross-to-Net January 28, 2021 Five Steps to GTN Implementation Success 3 Minute Read Pharmaceutical manufacturers can achieve GTN implementation success on day one of a new product launch by following these five best practices.
Gross-to-Net December 10, 2020 Gross-to-Net Roadmap to Launch 3 Minute Read A comprehensive countdown of the Top 10 key gross-to-net (GTN) milestones for manufacturers about to launch their first commercial product.
Gross-to-Net October 26, 2020 GTN Analytics: Improve Visibility and Predictability of Your Forecasting and Accrual... 3 Minute Read Data on Demand, GTN Reporting, Trends, and Metrics. Find out what's new in the latest ICyte Platform GTN Analytics release.
Contracts & Pricing October 15, 2020 Public Law Timeline for 2021, OIG Audit Report, Hot Topics at... 2 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Contracts & Pricing September 17, 2020 Additional Drug Reporting for NDA and ANDA Holders, FDA NSDE Structured... 2 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
